InvestorsHub Logo
Followers 43
Posts 2488
Boards Moderated 0
Alias Born 10/19/2015

Re: infitvest post# 325339

Wednesday, 08/11/2021 2:33:13 PM

Wednesday, August 11, 2021 2:33:13 PM

Post# of 463343
I wouldn't discount a complementary role for a partner -- I mentioned this with a possible AVXL / SAVA merger earlier, but CRTX may make more sense. It'll take a while though because while both drugs are safe on their own, a trial would be needed to study the safety and efficacy when taken together.

My concern is that the FDA won't want to approve more than 2 Alzheimer's drugs within a year. Aducanumab is a placeholder until something better comes along, so it's a race to see who gets to replace it. Anavex is probably on a slower track for Alzheimer's, which is why I like that Dr. Missling is also focusing on Rett and Parkinson's. If/when it gets approved for Alzheimer's, it'll boil down to the data and which drug is more effective between AVXL, CRTX and SAVA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News